author = {Viola Poeschel and Gerhard Held and Marita Ziepert and Mathias Witzens-Harig and Harald Holte and Lorenz Thurner and Peter Borchmann and Andreas Viardot and Martin Soekler and Ulrich Keller and Christian Schmidt and Lorenz Truemper and Rolf Mahlberg and Reinhard Marks and Heinz-Gert Hoeffkes and Bernd Metzner and Judith Dierlamm and Norbert Frickhofen and Mathias Haenel and Andreas Neubauer and Michael Kneba and Francesco Merli and Alessandra Tucci and Peter de Nully Brown and Massimo Federico and Eva Lengfelder and Alice di Rocco and Ralf Trappe and Andreas Rosenwald and Christian Berdel and Martin Maisenhoelder and Ofer Shpilberg and Josif Amam and Konstantinos Christofyllakis and Frank Hartmann and Niels Murawski and Stephan Stilgenbauer and Maike Nickelsen and Gerald Wulf and Bertram Glass and Norbert Schmitz and Bettina Altmann and Markus Loeffler and Michael Pfreundschuh},
    year = {2020},
    title = {Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial},
    journal = {Lancet},
    volume = {394(10216)},
    pages = {2271-2281}